Trial Profile
Randomized Controlled Pilot Trial Of Dapagliflozin In Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 15 May 2023
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 10 May 2023 Status changed from active, no longer recruiting to completed.
- 11 Apr 2022 Status changed from recruiting to active, no longer recruiting.
- 09 Sep 2020 Planned End Date changed from 1 Oct 2020 to 1 Oct 2022.